Traditional and Non-traditional Cardiovascular Risk Factors and Cardiovascular Disease in Women with Psoriasis
DOI:
https://doi.org/10.2340/actadv.v102.2244Keywords:
inflammatory skin disease, sex-specific, comorbidities, heart failure, myocardial infarction, cerebrovascular diseaseAbstract
Women with cardiovascular disease are underdiagnos-ed, undertreated and under-represented in research. Even though the increased risk of cardiovascular disease among patients with psoriasis is well establi-shed, only a few studies have examined women with psoriasis. This study examined the prevalence of cardio-vascular risk factors and cardiovascular disease among women with psoriasis. Using the Copenhagen City Heart Study and the Copenhagen General Population Study, 66,420 women were included in a cross-sectional design. Of these, 374 (0.56%) women had hospital-diagnosed psoriasis. Women with vs with-out hospital-diagnosed psoriasis had higher odds ratios of having traditional cardiovascular risk factors, including hypertriglyceridaemia, smoking, obesity, type 2 diabetes, and low physical activity, and of having non-traditional cardiovascular risk factors, including low level of education, high level of psycho-social stress, and low-grade inflammation. Compared with women from the general population, the multi-variable adjusted odds ratio of heart failure and ischaemic cerebrovascular disease in women with hospital-diagnosed psoriasis was 2.51 (95% confidence interval 1.33–4.73) and 2.06 (1.27–3.35). In conclusion, women with hospital-diagnosed psoriasis have a higher prevalence of traditional and non- traditional cardiovascular risk factors, and increased risk of heart failure and ischaemic cerebrovascular disease, even after adjusting for these cardiovascular risk factors.
Downloads
References
Get the facts about psoriasis and psoriatic arthritis:: National Psoriasis Foundation. [Accessed on July 6, 2021] Available from: https://www.psoriasis.org/psoriasis-statistics/
Yeung H, Takeshita J, Mehta NN, Kimmel SE, Ogdie A, Margolis DJ, et al. Psoriasis severity and the prevalence of major medical comorbidity: a population-based study. JAMA Dermatol 2013; 149: 1173-1179.
https://doi.org/10.1001/jamadermatol.2013.5015 DOI: https://doi.org/10.1001/jamadermatol.2013.5015
Takeshita J, Grewal S, Langan SM, Mehta NN, Ogdie A, Van Voorhees AS, et al. Psoriasis and comorbid diseases: epidemiology. J Am Acad Dermatol 2017; 76: 377-390.
https://doi.org/10.1016/j.jaad.2016.07.064 DOI: https://doi.org/10.1016/j.jaad.2016.07.064
Gelfand JM, Neimann AL, Shin DB, Wang X, Margolis DJ, Troxel AB. Risk of myocardial infarction in patients with psoriasis. J Am Med Assoc 2006; 296: 1735-1741.
https://doi.org/10.1001/jama.296.14.1735 DOI: https://doi.org/10.1001/jama.296.14.1735
Ahlehoff O, Gislason GH, Charlot M, Jørgensen CH, Lindhardsen J, Olesen JB, et al. Psoriasis is associated with clinically significant cardiovascular risk: a Danish nationwide cohort study. J Intern Med 2011; 270: 147-157.
https://doi.org/10.1111/j.1365-2796.2010.02310.x DOI: https://doi.org/10.1111/j.1365-2796.2010.02310.x
Miller IM, Ellervik C, Yazdanyar S, Jemec GBE. Meta-analysis of psoriasis, cardiovascular disease, and associated risk factors. J Am Acad Dermatol 2013; 69: 1014-1024.
https://doi.org/10.1016/j.jaad.2013.06.053 DOI: https://doi.org/10.1016/j.jaad.2013.06.053
Abuabara K, Azfar RS, Shin DB, Neimann AL, Troxel AB, Gelfand JM. Cause-specific mortality in patients with severe psoriasis: a population-based cohort study in the U.K. Br J Dermatol 2010; 163: 586-592.
https://doi.org/10.1111/j.1365-2133.2010.09941.x DOI: https://doi.org/10.1111/j.1365-2133.2010.09941.x
Armstrong AW, Harskamp CT, Armstrong EJ. Psoriasis and the risk of diabetes mellitus: a systematic review and meta-analysis. JAMA Dermatol 2013; 149: 84-91.
https://doi.org/10.1001/2013.jamadermatol.406 DOI: https://doi.org/10.1001/2013.jamadermatol.406
Armstrong AW, Harskamp CT, Dhillon JS, Armstrong EJ. Psoriasis and smoking: a systematic review and meta-analysis. Br J Dermatol 2014; 19: 304-314.
https://doi.org/10.1111/bjd.12670 DOI: https://doi.org/10.1111/bjd.12670
Lai YC, Yew YW. Psoriasis as an independent risk factor for cardiovascular disease: an epidemiologic analysis using a national database. J Cutan Med Surg 2016; 20: 327-333.
https://doi.org/10.1177/1203475415602842 DOI: https://doi.org/10.1177/1203475415602842
Boehncke W-H, Boehncke S, Tobin A-M, Kirby B. The "psoriatic march": a concept of how severe psoriasis may drive cardiovascular comorbidity. Exp Dermatol 2011; 20: 303-307.
https://doi.org/10.1111/j.1600-0625.2011.01261.x DOI: https://doi.org/10.1111/j.1600-0625.2011.01261.x
Hansson GK, Hermansson A. The immune system in atherosclerosis. Nat Immunol 2011; 12: 204-212.
https://doi.org/10.1038/ni.2001 DOI: https://doi.org/10.1038/ni.2001
Armstrong AW, Voyles S V., Armstrong EJ, Fuller EN, Rutledge JC. A tale of two plaques: convergent mechanisms of T-cell-mediated inflammation in psoriasis and atherosclerosis. Exp Dermatol 2011; 20: 544-549.
https://doi.org/10.1111/j.1600-0625.2011.01308.x DOI: https://doi.org/10.1111/j.1600-0625.2011.01308.x
Li WQ, Han JL, Manson JE, Rimm EB, Rexrode KM, Curhan GC, et al. Psoriasis and risk of nonfatal cardiovascular disease in U.S. women: a cohort study. Br J Dermatol 2012; 166: 811-818.
https://doi.org/10.1111/j.1365-2133.2011.10774.x DOI: https://doi.org/10.1111/j.1365-2133.2011.10774.x
Garshick MS, Vaidean G, Nikain CA, Chen Y, Smilowitz NR, Berger JS. Sex differences in the prevalence of vascular disease and risk factors in young hospitalized patients with psoriasis. Int J Womens Dermatol 2019; 5: 251-255.
https://doi.org/10.1016/j.ijwd.2019.05.003 DOI: https://doi.org/10.1016/j.ijwd.2019.05.003
Mehta LS, Beckie TM, DeVon HA, Grines CL, Krumholz HM, Johnson MN, et al. Acute myocardial infarction in women. Circulation 2016; 133: 916-947.
https://doi.org/10.1161/CIR.0000000000000351 DOI: https://doi.org/10.1161/CIR.0000000000000351
Vogel B, Acevedo M, Appelman Y, Bairey Merz CN, Chieffo A, Figtree GA, et al. The Lancet women and cardiovascular disease commission: reducing the global burden by 2030. Lancet 2021; 397: 2385-2438.
https://doi.org/10.1016/S0140-6736(21)00684-X DOI: https://doi.org/10.1016/S0140-6736(21)00684-X
Lindegard B. Diseases associated with psoriasis in a general population of 159,200 middle-aged, urban, native Swedes. Dermatologica 1986; 172: 298-304.
https://doi.org/10.1159/000249365 DOI: https://doi.org/10.1159/000249365
Danielsen K, Wilsgaard T, Olsen AO, Eggen AE, Olsen K, Cassano PA, et al. Elevated odds of metabolic syndrome in psoriasis: a population-based study of age and sex differences. Br J Dermatol 2015; 172: 419-427.
https://doi.org/10.1111/bjd.13288 DOI: https://doi.org/10.1111/bjd.13288
Sondermann W, Djeudeu Deudjui DA, Körber A, Slomiany U, Brinker TJ, Erbel R, et al. Psoriasis, cardiovascular risk factors and metabolic disorders: sex-specific findings of a population-based study. J Eur Acad Dermatol Venereol 2020; 34: 779-786.
https://doi.org/10.1111/jdv.16029 DOI: https://doi.org/10.1111/jdv.16029
Madsen CM, Varbo A, Nordestgaard BG. Extreme high high-density lipoprotein cholesterol is paradoxically associated with high mortality in men and women: two prospective cohort studies. Eur Heart J 2017; 38: 2478-2486.
https://doi.org/10.1093/eurheartj/ehx163 DOI: https://doi.org/10.1093/eurheartj/ehx163
Schmidt M, Pedersen L, Sørensen HT. The Danish Civil Registration System as a tool in epidemiology. Eur J Epidemiol 2014; 29: 541-549.
https://doi.org/10.1007/s10654-014-9930-3 DOI: https://doi.org/10.1007/s10654-014-9930-3
Schmidt M, Schmidt SAJ, Sandegaard JL, Ehrenstein V, Pedersen L, Sørensen HT. The Danish National Patient Registry: a review of content, data quality, and research potential. Clin Epidemiol 2015; 7: 449-490.
https://doi.org/10.2147/CLEP.S91125 DOI: https://doi.org/10.2147/CLEP.S91125
Egeberg A, Kristensen LE, Thyssen JP, Gislason GH, Gottlieb AB, Coates LC, et al. Incidence and prevalence of psoriatic arthritis in Denmark: a nationwide register linkage study. Ann Rheum Dis 2017; 76: 1591-1597.
https://doi.org/10.1136/annrheumdis-2016-210963 DOI: https://doi.org/10.1136/annrheumdis-2016-210963
Nordestgaard BG, Varbo A. Triglycerides and cardiovascular disease. Lancet 2014; 384: 626-635.
https://doi.org/10.1016/S0140-6736(14)61177-6 DOI: https://doi.org/10.1016/S0140-6736(14)61177-6
Ridker PM, Everett BM, Thuren T, MacFadyen JG, Chang WH, Ballantyne C, et al. Antiinflammatory therapy with canakinumab for atherosclerotic disease. N Engl J Med 2017; 377: 1119-1131.
https://doi.org/10.1056/NEJMoa1707914 DOI: https://doi.org/10.1056/NEJMoa1707914
Coimbra S, Oliveira H, Reis F, Belo L, Rocha S, Quintanilha A, et al. C-reactive protein and leucocyte activation in psoriasis vulgaris according to severity and therapy. J Eur Acad Dermatol Venereol 2010; 24: 789-796.
https://doi.org/10.1111/j.1468-3083.2009.03527.x DOI: https://doi.org/10.1111/j.1468-3083.2009.03527.x
Vachatova S, Andrys C, Krejsek J, Salavec M, Ettler K, Rehacek V, et al. Metabolic syndrome and selective inflammatory markers in psoriatic patients. J Immunol Res 2016; 2016: 1-8.
https://doi.org/10.1155/2016/5380792 DOI: https://doi.org/10.1155/2016/5380792
Ucak S, Ekmekci TR, Basat O, Koslu A, Altuntas Y. Comparison of various insulin sensitivity indices in psoriatic patients and their relationship with type of psoriasis. J Eur Acad Dermatol Venereol 2006; 20: 517-522.
https://doi.org/10.1111/j.1468-3083.2006.01499.x DOI: https://doi.org/10.1111/j.1468-3083.2006.01499.x
Boehncke S, Thaci D, Beschmann H, Ludwig RJ, Ackermann H, Badenhoop K, et al. Psoriasis patients show signs of insulin resistance. Br J Dermatol 2007; 157: 1249-1251.
https://doi.org/10.1111/j.1365-2133.2007.08190.x DOI: https://doi.org/10.1111/j.1365-2133.2007.08190.x
Gyldenløve M, Storgaard H, Holst JJ, Vilsbøll T, Knop FK, Skov L. Patients with psoriasis are insulin resistant. J Am Acad Dermatol 2015; 72: 599-605.
https://doi.org/10.1016/j.jaad.2015.01.004 DOI: https://doi.org/10.1016/j.jaad.2015.01.004
Gisondi P, Fantin F, Del Giglio M, Valbusa F, Marino F, Zamboni M, et al. Chronic plaque psoriasis is associated with increased arterial stiffness. Dermatology 2009; 218: 110-113.
https://doi.org/10.1159/000182256 DOI: https://doi.org/10.1159/000182256
Karadag AS, Yavuz B, Ertugrul DT, Akin KO, Yalcin AA, Deveci OS, et al. Is psoriasis a pre-atherosclerotic disease? Increased insulin resistance and impaired endothelial function in patients with psoriasis. Int J Dermatol 2010; 49: 642-646.
https://doi.org/10.1111/j.1365-4632.2009.04358.x DOI: https://doi.org/10.1111/j.1365-4632.2009.04358.x
Garshick MS, Barrett TJ, Wechter T, Azarchi S, Scher JU, Neimann A, et al. Inflammasome signaling and impaired vascular health in psoriasis. Arterioscler Thromb Vasc Biol 2019; 39: 787-798.
https://doi.org/10.1161/ATVBAHA.118.312246 DOI: https://doi.org/10.1161/ATVBAHA.118.312246
Setty AR, Curhan G, Choi HK. Obesity, waist circumference, weight change, and the risk of psoriasis in women: nurses' health study II. Arch Intern Med 2007; 167: 1670-1675.
https://doi.org/10.1001/archinte.167.15.1670 DOI: https://doi.org/10.1001/archinte.167.15.1670
La Sala L, Pontiroli AE. Prevention of diabetes and cardiovascular disease in obesity. Int J Mol Sci 2020; 21: 8178.
https://doi.org/10.3390/ijms21218178 DOI: https://doi.org/10.3390/ijms21218178
Kolb H, Martin S. Environmental/lifestyle factors in the pathogenesis and prevention of type 2 diabetes. BMC Med 2017; 15: 131.
https://doi.org/10.1186/s12916-017-0901-x DOI: https://doi.org/10.1186/s12916-017-0901-x
Qureshi AA, Choi HK, Setty AR, Curhan GC. Psoriasis and the risk of diabetes and hypertension: a prospective study of us female nurses. Arch Dermatol 2009; 145: 379-382.
https://doi.org/10.1001/archdermatol.2009.48 DOI: https://doi.org/10.1001/archdermatol.2009.48
Frankel HC, Han J, Li T, Qureshi AA. The association between physical activity and the risk of incident psoriasis. Arch Dermatol 2012; 148: 918-924.
https://doi.org/10.1001/archdermatol.2012.943 DOI: https://doi.org/10.1001/archdermatol.2012.943
Ahlehoff O, Skov L, Gislason G, Lindhardsen J, Kristensen SL, Iversen L, et al. Pharmacological undertreatment of coronary risk factors in patients with psoriasis: observational study of the Danish nationwide registries. PLoS One 2012; 7:e36342.
https://doi.org/10.1371/journal.pone.0036342 DOI: https://doi.org/10.1371/journal.pone.0036342
Kimball AB, Szapary P, Mrowietz U, Reich K, Langley RG, You Y, et al. Underdiagnosis and undertreatment of cardiovascular risk factors in patients with moderate to severe psoriasis. J Am Acad Dermatol 2012; 67: 76-85.
https://doi.org/10.1016/j.jaad.2011.06.035 DOI: https://doi.org/10.1016/j.jaad.2011.06.035
Khalid U, Ahlehoff O, Gislason GH, Kristensen SL, Skov L, Torp-Pedersen C, et al. Psoriasis and risk of heart failure: a nationwide cohort study. Eur J Heart Fail 2014; 16: 743-748.
https://doi.org/10.1002/ejhf.113 DOI: https://doi.org/10.1002/ejhf.113
Regitz-Zagrosek V, Kararigas G. Mechanistic pathways of sex differences in cardiovascular disease. Physiol Rev 2017; 97: 1-37.
https://doi.org/10.1152/physrev.00021.2015 DOI: https://doi.org/10.1152/physrev.00021.2015
Bergami M, Scarpone M, Bugiardini R, Cenko E, Manfrini O. Sex beyond cardiovascular risk factors and clinical biomarkers of cardiovascular disease. Rev Cardiovasc Med 2022; 23: 19.
https://doi.org/10.31083/j.rcm2301019 DOI: https://doi.org/10.31083/j.rcm2301019
Tur E, Maibach HI. Gender and dermatology. Springer; 2018: p. 63-73.
https://doi.org/10.1007/978-3-319-72156-9 DOI: https://doi.org/10.1007/978-3-319-72156-9
Parisi R, Rutter MK, Lunt M, Young HS, Symmons DPM, Griffiths CEM, et al. Psoriasis and the risk of major cardiovascular events: cohort study using the clinical practice research datalink. J Invest Dermatol 2015; 135: 2189-2197.
https://doi.org/10.1038/jid.2015.87 DOI: https://doi.org/10.1038/jid.2015.87
Additional Files
Published
How to Cite
Issue
Section
Categories
License
Copyright (c) 2022 Charlotte Näslund-Koch, Signe Vedel-Krogh, Stig Egil Bojesen, Lone Skov
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All digitalized ActaDV contents is available freely online. The Society for Publication of Acta Dermato-Venereologica owns the copyright for all material published until volume 88 (2008) and as from volume 89 (2009) the journal has been published fully Open Access, meaning the authors retain copyright to their work.
Unless otherwise specified, all Open Access articles are published under CC-BY-NC licences, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material for non-commercial purposes, provided proper attribution to the original work.
